Eureka Therapeutics and Memorial Sloan-Kettering Cancer Center licenses anticancer MAb to Novartis Jan. 31, 2014
Amarantus and Boston University to evaluate test for early signs of neurodegenerative diseases Jan. 31, 2014
Biogen and UCB sign exclusive agreements to commercialize therapies for MS and hemophilia in Asia Jan. 30, 2014
RSS